ConductScience.org, home

Trial · NCT04673214

Results by group86

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.DOUBLE THERAPYCough7Standard Deviation 5.4days
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.TRIPLE THERAPYCough7Standard Deviation 5.6days
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.DOUBLE THERAPYFever2Standard Deviation 3.4days
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.TRIPLE THERAPYFever2Standard Deviation 3.2days
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.DOUBLE THERAPYHeadache6Standard Deviation 5.2days
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.TRIPLE THERAPYHeadache5Standard Deviation 4.9days
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.DOUBLE THERAPYRhinorrhea3Standard Deviation 4.8days
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.TRIPLE THERAPYRhinorrhea3Standard Deviation 4.3days
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.DOUBLE THERAPYOdynophagia5Standard Deviation 4.8days
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.TRIPLE THERAPYOdynophagia5Standard Deviation 5.4days
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.DOUBLE THERAPYDiarrhea2Standard Deviation 4days
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.TRIPLE THERAPYDiarrhea1Standard Deviation 2.2days
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.DOUBLE THERAPYMyalgia6Standard Deviation 5.6days
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.TRIPLE THERAPYMyalgia5Standard Deviation 5days
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.DOUBLE THERAPYAnosmia5Standard Deviation 5.8days
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.TRIPLE THERAPYAnosmia6Standard Deviation 5.9days
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.DOUBLE THERAPYConjunctivitis2Standard Deviation 4.1days
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.TRIPLE THERAPYConjunctivitis1Standard Deviation 2.9days
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.DOUBLE THERAPYChest pain5Standard Deviation 5.6days
Average Days in COVID-19 Symptoms by Type of Therapy in the UMF 20 and UMF 13 of the IMSS.TRIPLE THERAPYChest pain4Standard Deviation 4.8days

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04673214/results